Articles related to PEER-TO-PEER

Leqembi, a newly FDA-approved drug, has shown promising results in clinical trials, resulting in a 28% slower decline in Alzheimer’s patients compared to placebo. This equates to an additional four to five months of retained function.

In addition to being stigmatized and vulnerable, people with intellectual or developmental disabilities are severely undercounted and underrepresented in medical research. This highlights the urgent need for more inclusive research and resources to ensure equitable cancer treatment for this population.

Did you know that over-hiring doctors can lead to more innovative opportunities within your practice? Dr. Laurie Sorrenson’s experience proves that what may initially seem like an excessive decision can turn out to be a fantastic move.

Delve deeper into this issue and consider its potential implications for our healthcare system. Your insights and perspectives could contribute significantly to this important debate.

Dr. David Hirshfield’s top takeaways can help better prepare you for what lies ahead in retirement. Step one? Plan ahead.

Explore how aging and personal health risks can transform a physician’s perspective on patient care. Learn about the shift from objectivity to empathy in physician-patient relationships.